name: Celiac Disease
category: Complex
parents:
- Gastrointestinal Disease
- Autoimmune Disease
disease_term:
  preferred_term: celiac disease
  term:
    id: MONDO:0005130
    label: celiac disease
pathophysiology:
- name: Gluten-Triggered Immune Response
  description: >
    Gluten peptides (gliadin) cross the intestinal epithelium and are
    deamidated by tissue transglutaminase (tTG). Deamidated peptides
    bind HLA-DQ2/DQ8 and activate CD4+ T cells.
  cell_types:
  - preferred_term: T Helper Cell
    term:
      id: CL:0000492
      label: CD4-positive helper T cell
  biological_processes:
  - preferred_term: Antigen Processing
    term:
      id: GO:0019882
      label: antigen processing and presentation
  evidence:
  - reference: PMID:10684852
    supports: SUPPORT
    snippet: "tissue transglutaminase (tTG)-mediated deamidation of gliadin plays an important role in recognition of this food antigen by intestinal T cells"
    explanation: Demonstrates the critical role of tTG deamidation in converting gluten peptides into immunogenic epitopes recognized by T cells in celiac disease.
  - reference: PMID:10684852
    supports: SUPPORT
    snippet: "the deamidated peptides displayed an increased affinity for DQ2, a molecule known to preferentially bind peptides containing negatively charged residues"
    explanation: Shows how tTG deamidation increases HLA-DQ2 binding affinity by introducing negatively charged glutamate residues, enhancing antigen presentation.
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "Transglutaminase 2 (TG2) plays a pivotal role in the pathogenesis of celiac disease (CeD) by deamidating dietary gluten peptides, which facilitates antigenic presentation and a strong anti-gluten T cell response."
    explanation: Confirms TG2 deamidation as the pivotal mechanism enabling gluten peptide presentation and T cell activation in celiac disease pathogenesis.
- name: Intestinal Epithelial Damage
  description: >
    Activated T cells release IFN-gamma and other cytokines causing
    villous atrophy, crypt hyperplasia, and increased intraepithelial
    lymphocytes. Leads to malabsorption.
  cell_types:
  - preferred_term: Intestinal Epithelial Cell
    term:
      id: CL:0002563
      label: intestinal epithelial cell
  biological_processes:
  - preferred_term: Apoptosis
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "Nearly half of the gluten-induced gene expression changes in CeD were associated with the epithelial interferon-Î³ response."
    explanation: Demonstrates that IFN-gamma signaling drives a major portion of the transcriptional changes underlying epithelial damage in celiac disease.
  - reference: PMID:15357947
    supports: SUPPORT
    snippet: "under conditions of dysregulated IL15 expression in vivo in patients with celiac disease and in vitro in healthy individuals, multiple steps of the NKG2D/DAP10 signaling pathway leading to ERK and JNK activation are coordinately primed to activate direct cytolytic function independent of TCR specificity in effector CD8 T cells"
    explanation: Shows how IL-15 converts intraepithelial CD8+ T cells into cytotoxic lymphokine-activated killer cells via NKG2D signaling, mediating epithelial damage.
  - reference: PMID:24942692
    supports: SUPPORT
    snippet: "the upregulation of IL-15 expression in the intestinal mucosa has become a hallmark of the disease"
    explanation: Identifies IL-15 upregulation as a defining feature of celiac disease that drives intraepithelial lymphocyte expansion and epithelial injury.
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
    explanation: Provides interventional evidence that blocking TG2-mediated T cell activation prevents the downstream epithelial damage, villous atrophy, and malabsorption.
- name: Autoantibody Production
  description: >
    B cells produce antibodies against tTG (anti-tTG IgA) and
    deamidated gliadin peptides (anti-DGP). These serve as diagnostic
    markers and may contribute to pathology.
  cell_types:
  - preferred_term: Plasma Cell
    term:
      id: CL:0000786
      label: plasma cell
  evidence:
  - reference: PMID:39273359
    supports: SUPPORT
    snippet: "Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed \"gluten\", in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."
    explanation: Describes the immune-mediated nature of celiac disease, which includes both cellular and humoral (antibody) responses to gluten antigens.
- name: Barrier Dysfunction
  description: >
    Increased intestinal permeability allows greater gluten peptide
    translocation. Zonulin upregulation disrupts tight junctions.
  evidence:
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
    explanation: Blocking TG2 prevents gluten-induced disruption of epithelial barrier integrity and differentiation programs, indicating barrier dysfunction is downstream of adaptive immune activation.
phenotypes:
- name: Chronic Diarrhea
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Chronic Diarrhea
    term:
      id: HP:0002028
      label: Chronic diarrhea
  evidence:
  - reference: PMID:39273359
    supports: SUPPORT
    snippet: "CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage."
    explanation: Chronic inflammation and mucosal damage from immune response to gluten leads to malabsorption and chronic diarrhea as a cardinal symptom.
- name: Abdominal Pain
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abdominal Pain
    term:
      id: HP:0002027
      label: Abdominal pain
- name: Bloating
  category: Gastrointestinal
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abdominal Distention
    term:
      id: HP:0003270
      label: Abdominal distention
- name: Weight Loss
  category: Systemic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Weight Loss
    term:
      id: HP:0001824
      label: Weight loss
  evidence:
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
    explanation: Weight loss results from impaired nutrient absorption due to villous atrophy and loss of epithelial cell differentiation and absorptive capacity.
- name: Iron Deficiency Anemia
  category: Hematologic
  frequency: FREQUENT
  notes: From malabsorption
  phenotype_term:
    preferred_term: Anemia
    term:
      id: HP:0001903
      label: Anemia
  evidence:
  - reference: PMID:38914866
    supports: SUPPORT
    snippet: "ZED1227 treatment preserved transcriptome signatures associated with mucosal morphology, inflammation, cell differentiation and nutrient absorption to the level of the gluten-free diet group."
    explanation: Anemia results from malabsorption of iron and other nutrients due to villous atrophy and impaired epithelial absorptive function in damaged small intestine.
- name: Fatigue
  category: Systemic
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- name: Dermatitis Herpetiformis
  category: Dermatological
  frequency: OCCASIONAL
  notes: Skin manifestation of celiac
  phenotype_term:
    preferred_term: Skin Rash
    term:
      id: HP:0000988
      label: Skin rash
- name: Osteoporosis
  category: Musculoskeletal
  frequency: OCCASIONAL
  notes: From calcium/vitamin D malabsorption
  phenotype_term:
    preferred_term: Reduced Bone Density
    term:
      id: HP:0004349
      label: Reduced bone mineral density
biochemical:
- name: Anti-tTG IgA
  presence: Elevated
  context: Primary diagnostic marker
- name: Anti-Endomysial Antibodies
  presence: Elevated
  context: Highly specific
- name: Anti-DGP Antibodies
  presence: Elevated
  context: Useful when IgA deficient
- name: Total IgA
  presence: Variable
  context: IgA deficiency common in celiac
genetic:
- name: HLA-DQ2
  association: Risk Factor
  notes: Present in ~95% of patients
- name: HLA-DQ8
  association: Risk Factor
  notes: Most remaining patients
- name: IL2
  association: Risk Factor
- name: IL21
  association: Risk Factor
environmental:
- name: Gluten Exposure
  notes: Required trigger
- name: Early Gluten Introduction
  notes: Timing may affect risk
- name: Gastrointestinal Infections
  notes: May trigger onset
- name: Gut Microbiome
  notes: May modulate risk
treatments:
- name: Gluten-Free Diet
  description: Lifelong strict gluten avoidance is the only effective treatment.
  treatment_term:
    preferred_term: dietary gluten intake avoidance
    term:
      id: MAXO:0010000
      label: dietary gluten intake avoidance
- name: Nutritional Supplementation
  description: Iron, calcium, vitamin D, B12 as needed.
  treatment_term:
    preferred_term: nutritional supplementation
    term:
      id: MAXO:0000106
      label: nutritional supplementation
- name: Monitoring
  description: Regular serology and bone density monitoring.
  treatment_term:
    preferred_term: disease screening
    term:
      id: MAXO:0000124
      label: disease screening
- name: Corticosteroids
  description: For refractory celiac disease.
  treatment_term:
    preferred_term: corticosteroid agent therapy
    term:
      id: MAXO:0000640
      label: corticosteroid agent therapy
- name: Dietitian Counseling
  description: Essential for dietary compliance.
  treatment_term:
    preferred_term: dietician evaluation
    term:
      id: MAXO:0000919
      label: dietician evaluation
datasets:
# Celiac Disease Microbiome Studies
- accession: sra:PRJNA486782
  title: Prospective metagenomics of infants at risk for celiac disease
  description: >-
    Longitudinal metagenomic analysis tracking gut microbiota shifts before celiac
    disease development. Cross-sectional and longitudinal analyses of microbiota,
    functional pathways, and metabolites starting 18 months before CD onset.
  organism:
    preferred_term: human gut metagenome
    term:
      id: NCBITaxon:408170
      label: human gut metagenome
  data_type: WGS
  sample_types:
    - preferred_term: fecal sample
      tissue_term:
        preferred_term: feces
        term:
          id: UBERON:0001988
          label: feces
  conditions:
    - at-risk infants who developed celiac disease
    - at-risk infants who did not develop celiac disease
  notes: PNAS 2021 - microbiome signatures preceding CD onset

- accession: sra:PRJNA812940
  title: Biogeographic variation of gut microbiota in celiac disease
  description: >-
    16S rRNA gene sequencing of duodenal aspirates (luminal), duodenal biopsies,
    and feces from patients with celiac disease and controls. Identified altered
    microbial communities in CeD specific to the small intestine.
  organism:
    preferred_term: human gut metagenome
    term:
      id: NCBITaxon:408170
      label: human gut metagenome
  sample_types:
    - preferred_term: duodenal sample
      tissue_term:
        preferred_term: duodenum
        term:
          id: UBERON:0002114
          label: duodenum
    - preferred_term: fecal sample
      tissue_term:
        preferred_term: feces
        term:
          id: UBERON:0001988
          label: feces
  conditions:
    - celiac disease
    - healthy controls
  notes: Gastroenterology 2022 - small intestine-specific dysbiosis

- accession: sra:PRJNA631001
  title: Pre-celiac microbiome metabolic pathways in children
  description: >-
    16S rRNA sequencing predicting distinct metabolic pathways among gut microbiota
    in children who later develop celiac disease, years before diagnosis.
  organism:
    preferred_term: human gut metagenome
    term:
      id: NCBITaxon:408170
      label: human gut metagenome
  sample_types:
    - preferred_term: fecal sample
      tissue_term:
        preferred_term: feces
        term:
          id: UBERON:0001988
          label: feces
  conditions:
    - children who developed celiac disease
    - children who remained healthy
  notes: Microbiology Spectrum 2025 - predictive microbiome signatures

- accession: sra:PRJNA904924
  title: Non-responsive celiac disease microbiome and metabolome
  description: >-
    Shotgun metagenomics from 39 non-responsive celiac disease (NRCD) patients
    integrating fecal metagenomics, mucosal integrity markers, and metabolomics.
  organism:
    preferred_term: human gut metagenome
    term:
      id: NCBITaxon:408170
      label: human gut metagenome
  data_type: WGS
  sample_types:
    - preferred_term: fecal sample
      tissue_term:
        preferred_term: feces
        term:
          id: UBERON:0001988
          label: feces
  sample_count: 39
  conditions:
    - non-responsive celiac disease on GFD
  notes: mSystems 2025 - refractory CeD microbiome

- accession: sra:PRJNA1023737
  title: One year gluten-free diet impacts on gut function and microbiome
  description: >-
    Shotgun metagenomics from 36 newly diagnosed patients and 36 healthy volunteers
    at baseline and 12-month follow-up. MRI gut function and metagenomics.
  organism:
    preferred_term: human gut metagenome
    term:
      id: NCBITaxon:408170
      label: human gut metagenome
  data_type: WGS
  sample_types:
    - preferred_term: fecal sample
      tissue_term:
        preferred_term: feces
        term:
          id: UBERON:0001988
          label: feces
  sample_count: 72
  conditions:
    - newly diagnosed celiac disease baseline
    - celiac disease 12 months on GFD
    - healthy controls
  notes: Clinical Gastroenterology Hepatology 2024
